Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyAnna DeFazio, Martin Köbel, Jason Madore et al.|British Journal of Cancer|2014Cited by 113
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Michael Schneider, Dominique‐Laurent Couturier et al.|British Journal of Cancer|2020Cited by 68
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Jennifer Alsop et al.|The Journal of Pathology Clinical Research|2023Cited by 29
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|Clinical Cancer Research|2024Cited by 14
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|medRxiv|2023Cited by 5